Total trials
317
Active
72
Phase 3
11
Total enrollment
80,520
Pipeline matrix
Showing 21 of 21 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Normal saline | — | — | — | — | — | 2 | |
| Drug administration according to protocol | — | — | — | — | — | 1 | |
| lixisenatide + glargine | — | — | — | — | — | 1 | |
| Intensive insulin therapy | — | — | — | — | — | 1 | |
| Pregabalin 150mg | — | — | — | — | — | 1 | |
| Prednisone | — | — | — | — | — | 1 | |
| Azathioprine | — | — | — | — | — | 1 | |
| Intravenous magnesium sulfate | — | — | — | — | — | 1 | |
| budesonide | — | — | — | — | — | 1 | |
| omeprazole | — | — | — | — | — | 1 | |
| Salbutamol | — | — | — | — | — | 1 | |
| 0,9% Chloride Sodium | — | — | — | — | — | 1 | |
| A - Allogenic ADSC cells in fibrin solution - two times administration ADSC/ASC | — | — | — | — | — | 1 | |
| B - Allogenic ADSC cells in fibrin solution - one time administration of ADSC/ASC, one time of placebo | — | — | — | — | — | 1 | |
| Trametinib | — | — | — | — | — | 1 | |
| Standard therapy | — | — | — | — | — | 1 | |
| lidocaine | — | — | — | — | 2 | ||
| Fidaxomicin | — | — | — | — | — | 1 | |
| Vancomycin (VAN) treatment | — | — | — | — | — | 1 | |
| Cashew immunotherapy | — | — | — | — | — | 1 | |
| Non-selective beta-blockers | — | — | — | — | — | 1 |
Next readouts
- 2025-04-01
- 2025-11-30
- 2026-04-21
- 2026-08-01
- 2027-02-28
- 2027-03-02
- 2027-03-31
- 2027-06-01
- 2027-09-01
- 2027-09-30
Top conditions
- Heart Failure14
- Food Allergy8
- Obesity7
- Knee Osteoarthritis6
- Atrial Fibrillation5
- Asthma5
- Diarrhea5
- Constipation5
Frequently asked questions about Medical University of Warsaw
- How many clinical trials does Medical University of Warsaw have on ClinicalTrials.gov?
- Medical University of Warsaw is listed as the lead sponsor on 317 clinical trials in ClinicalTrials.gov, 72 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of Warsaw's trials are in Phase 3?
- 11 of Medical University of Warsaw's trials are in Phase 3, spread across 21 active drug programs.
- What therapeutic areas does Medical University of Warsaw focus on?
- Medical University of Warsaw's most-studied conditions on ClinicalTrials.gov are Heart Failure, Food Allergy, Obesity, Knee Osteoarthritis, Atrial Fibrillation.
- When are Medical University of Warsaw's next clinical trial readouts?
- Medical University of Warsaw has 10 upcoming primary-completion readouts tracked here; the soonest is “Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).”, expected around 2025-04-01.